Skip to content
The Policy VaultThe Policy Vault

Actemra — Blue Cross Blue Shield of Kansas

systemic sclerosis associated interstitial lung disease (SSc-ILD)

Initial criteria

  • Request is for Actemra syringe (Actemra ACTpen not approvable for SSc-ILD).

Approval duration

12 months